Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Evotec SE (EVO) EBT: 2009-2024

Historic EBT for Evotec SE (EVO) over the last 7 years, with Dec 2024 value amounting to -$207.3 million.

  • Evotec SE's EBT rose 2.44% to -$50,223 in Q3 2025 from the same period last year, while for Sep 2025 it was -$293.8 million, marking a year-over-year decrease of 239.01%. This contributed to the annual value of -$207.3 million for FY2024, which is 139.04% down from last year.
  • Per Evotec SE's latest filing, its EBT stood at -$207.3 million for FY2024, which was down 139.04% from -$86.7 million recorded in FY2023.
  • Evotec SE's 5-year EBT high stood at $271.1 million for FY2021, and its period low was -$207.3 million during FY2024.
  • Moreover, its 3-year median value for EBT was -$157.1 million (2022), whereas its average is -$150.4 million.
  • As far as peak fluctuations go, Evotec SE's EBT skyrocketed by 779.94% in 2021, and later tumbled by 157.94% in 2022.
  • Yearly analysis of 5 years shows Evotec SE's EBT stood at $30.8 million in 2020, then surged by 779.94% to $271.1 million in 2021, then tumbled by 157.94% to -$157.1 million in 2022, then soared by 44.79% to -$86.7 million in 2023, then tumbled by 139.04% to -$207.3 million in 2024.